Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Cross-over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors

NCT00221195 is registered in ClinicalTrials.gov with Tulane University School of Medicine as lead sponsor.

NCT NCT00221195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00221195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Cross-over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors
Lead sponsor
Tulane University School of Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2003
Completion date
July 31, 2010
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitors